Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia


We describe a patient with acute promyelocytic leukemia (APL) who was successfully induced into remission with all-trans retinoic acid (ATRA) and idarubicin, but developed myelodysplastic syndrome (MDS) with monosomy 7 shortly after conclusion of maintenance therapy with idarubicin alternating with 6-mercaptopurine, vincristine, methotrexate and prednisone. Patients on combination regimens of ATRA or other retinoids and chemotherapy, which are being increasingly used in recent years, should be closely monitored for the development of potentially new complications including MDS.

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bseiso, A., Kantarjian, H. & Estey, E. Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia. Leukemia 11, 168–169 (1997).

Download citation


  • secondary myelodysplastic syndrome
  • acute promyelocytic leukemia

Further reading


Quick links